Open AccessThis article is
- freely available
Selective Cytotoxicity of Goniothalamin against Hepatoblastoma HepG2 Cells
Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, University Putra Malaysia (UPM), 43400, Serdang, Selangor, Malaysia
Department of Obstetric and Gynaecology, Faculty of Medicine and Health Sciences, University Putra Malaysia (UPM), 43400, Serdang, Selangor, Malaysia
Department of Veterinary Pathology and Microbiology, Faculty of Veterinary Medicine, University Putra Malaysia (UPM), 43400, Serdang, Selangor, Malaysia
Faculty of Agriculture and Biotechnology, University Sultan Zainal Abidin (UniSZA), Kampus Kota, Jalan Sultan Mahmud, 20400 Kuala Terengganu, Malaysia
* Author to whom correspondence should be addressed.
Received: 17 January 2011; in revised form: 11 March 2011 / Accepted: 17 March 2011 / Published: 6 April 2011
Abstract: Liver cancer has become one of the major types of cancer with high mortality and liver cancer is not responsive to the current cytotoxic agents used in chemotherapy. The purpose of this study was to examine the in vitro cytotoxicity of goniothalamin on human hepatoblastoma HepG2 cells and normal liver Chang cells. The cytotoxicity of goniothalamin against HepG2 and liver Chang cell was tested using MTT cell viability assay, LDH leakage assay, cell cycle flow cytometry PI analysis, BrdU proliferation ELISA assay and trypan blue dye exclusion assay. Goniothalamin selectively inhibited HepG2 cells [IC50 = 4.6 (±0.23) µM in the MTT assay; IC50 = 5.20 (±0.01) µM for LDH assay at 72 hours], with less sensitivity in Chang cells [IC50 = 35.0 (±0.09) µM for MTT assay; IC50 = 32.5 (±0.04) µM for LDH assay at 72 hours]. In the trypan blue dye exclusion assay, the Viability Indexes were 52 ± 1.73% for HepG2 cells and 62 ± 4.36% for Chang cells at IC50 after 72 hours. Cytotoxicity of goniothalamin was related to inhibition of DNA synthesis, as revealed by the reduction of BrdU incorporation. At 72 hours, the lowest concentration of goniothalamin (2.3 µL) retained 97.6% of normal liver Chang cells proliferation while it reduced HepG2 cell proliferation to 19.8% as compared to control. Besides, goniothalamin caused accumulation of hypodiploid apoptosis and different degree of G2/M arrested as shown in cell cycle analysis by flow cytometry. Goniothalamin selectively killed liver cancer cell through suppression of proliferation and induction of apoptosis. These results suggest that goniothalamin shows potential cytotoxicity against hepatoblastoma HepG2 cells.
Keywords: goniothalamin; HepG2 cell; liver Chang cell; cytotoxicity
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Al-Qubaisi, M.; Rozita, R.; Yeap, S.-K.; Omar, A.-R.; Ali, A.-M.; Alitheen, N.B. Selective Cytotoxicity of Goniothalamin against Hepatoblastoma HepG2 Cells. Molecules 2011, 16, 2944-2959.
Al-Qubaisi M, Rozita R, Yeap S-K, Omar A-R, Ali A-M, Alitheen NB. Selective Cytotoxicity of Goniothalamin against Hepatoblastoma HepG2 Cells. Molecules. 2011; 16(4):2944-2959.
Al-Qubaisi, Mothanna; Rozita, Rosli; Yeap, Swee-Keong; Omar, Abdul-Rahman; Ali, Abdul-Manaf; Alitheen, Noorjahan B. 2011. "Selective Cytotoxicity of Goniothalamin against Hepatoblastoma HepG2 Cells." Molecules 16, no. 4: 2944-2959.